![]()
|
|
||||||||
J. Biol. Chem., Vol. 279, Issue 45, 46882-46889, November 5, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1-Adrenergic Receptor to Agonist-induced Ubiquitination

From the Membrane Biochemistry Section, Laboratory of Molecular and Cellular Neurobiology, NINDS, National Institutes of Health, Bethesda, Maryland 20892
Down-regulation is a classic response of most G protein-coupled receptors to prolonged agonist stimulation. We recently showed that when expressed in baby hamster kidney cells, the human
1-but not the
2-adrenergic receptor (AR) is totally resistant to agonist-mediated down-regulation, whereas both have similar rates of basal degradation (Liang, W., Austin, S., Hoang, Q., and Fishman, P. H. (2003) J. Biol. Chem. 278, 3977339781). To identify the underlying mechanism(s) for this resistance, we investigated the role of proteasomes, lysosomes, and ubiquitination in the degradation of
1AR expressed in baby hamster kidney and human embryonic kidney 293 cells. Both lysosomal and proteasomal inhibitors reduced
1AR degradation in agonist-stimulated cells but were less effective on basal degradation. To determine whether
1AR trafficked to lysosomes we used confocal fluorescence microscopy. We observed some colocalization of
1AR and lysosomal markers in agonist-treated cells but much less than that of
2AR even in cells co-transfected with arrestin-2, which increases
1AR internalization. Ubiquitination of
2AR readily occurred in agonist-stimulated cells, whereas ubiquitination of
1AR was not detectable even under conditions optimal for that of
2AR. Moreover, in cells expressing
AR chimeras in which the C termini have been switched, the chimeric
1AR with
2AR C-tail underwent ubiquitination and down-regulation, but the chimeric
2AR with
1AR C-tail did not. Our results demonstrate for the first time that
1AR and
2AR differ in the ability to be ubiquitinated. Because ubiquitin serves as a signal for sorting membrane receptors to lysosomes, the lack of agonist-mediated ubiquitination of
1AR may prevent its extensive trafficking to lysosomes and, thus, account for its resistance to down-regulation.
Received for publication, June 11, 2004 , and in revised form, July 28, 2004.
* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed: Bldg. 49, Rm. 2A28, 49 Convent Dr., MSC4440, NIH, Bethesda, MD 20892-4440. Tel.: 301-496-1325; Fax: 301-496-8244; E-mail: fishmanp{at}ninds.nih.gov.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
J.-G. Li, D. S. Haines, and L.-Y. Liu-Chen Agonist-Promoted Lys63-Linked Polyubiquitination of the Human {kappa}-Opioid Receptor Is Involved in Receptor Down-Regulation Mol. Pharmacol., April 1, 2008; 73(4): 1319 - 1330. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Shenoy Seven-Transmembrane Receptors and Ubiquitination Circ. Res., April 27, 2007; 100(8): 1142 - 1154. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Gonzalez-Cabrera, T. Hla, and H. Rosen Mapping Pathways Downstream of Sphingosine 1-Phosphate Subtype 1 by Differential Chemical Perturbation and Proteomics J. Biol. Chem., March 9, 2007; 282(10): 7254 - 7264. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Tran, J. Friedman, F. Baameur, B. J. Knoll, R. H. Moore, and R. B. Clark Characterization of beta2-Adrenergic Receptor Dephosphorylation: Comparison with the Rate of Resensitization Mol. Pharmacol., January 1, 2007; 71(1): 47 - 60. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Drake, S. K. Shenoy, and R. J. Lefkowitz Trafficking of G Protein-Coupled Receptors Circ. Res., September 15, 2006; 99(6): 570 - 582. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |